1. Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations. Issue 5 (September 2019) Authors: Modi, Nishit B.; Mittur, Aravind; Dinh, Phillip; Rubens, Robert; Gupta, Suneel Journal: Clinical neuropharmacology Issue: Volume 42:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics, distribution, metabolism, and excretion of the dual reuptake inhibitor [14C]-nefopam in rats. (1st November 2016) Authors: Yu, Jian; Solon, Eric; Shen, Helen; Modi, Nishit B.; Mittur, Aravind Journal: Xenobiotica Issue: Volume 46:Number 11(2016:Nov.) Page Start: 1026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetics, metabolism, and excretion of nefopam, a dual reuptake inhibitor in healthy male volunteers. (1st November 2016) Authors: Sanga, Madhu; Banach, John; Ledvina, Aaron; Modi, Nishit B.; Mittur, Aravind Journal: Xenobiotica Issue: Volume 46:Number 11(2016:Nov.) Page Start: 1001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules. Issue 1 (January 2019) Authors: Modi, Nishit B.; Mittur, Aravind; Rubens, Robert; Khanna, Sarita; Gupta, Suneel Journal: Clinical neuropharmacology Issue: Volume 42:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗